Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esther Melamed

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 2025
Evaluating COVID-19 severity prediction and immune dynamics with NULISAseq: Insights from the IMPACC studyKoji Abe, Tyson H Holmes, Tran T Nguyen, et al.
Ebiomedicine|August 11, 2022
Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC studyAl Ozonoff, Joanna Schaenman, Naresh Doni Jayavelu, et al.
Research Square|June 30, 2025
Empiric Azithromycin in COVID-19 Impacts the Respiratory Microbiome and Antimicrobial Resistome without Anti-inflammatory BenefitCharles Langelier, Abigail Glascock, Cole Maguire, et al.
The Journal of Allergy and Clinical Immunology. Global|July 25, 2025
Type 2 immune responses are associated with less severe COVID-19 in a hospitalized cohortNaresh Doni Jayavelu, Jingjing Qi, Carly E Milliren, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 4, 2015
Update on biomarkers in neuromyelitis opticaEsther Melamed, Michael Levy, Patrick J Waters, et al.
Medrxiv : the Preprint Server for Health Sciences|February 24, 2025
Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factorsNaresh Doni Jayavelu, Hady Samaha, Sonia Tandon Wimalasena, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2025
Identification of a multi-omics factor predictive of long COVID in the IMPACC studyGisela Gabernet, Jessica Maciuch, Jeremy P Gygi, et al.
JCI Insight|July 3, 2025
MICBG406A polymorphism reduces risk of mechanical ventilation and death during viral acute lung injuryHarry Pickering, Narges Alipanah-Lechner, Ernie Chen, et al.
Communications Medicine|January 3, 2026
Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factorsNaresh Doni Jayavelu, Hady Samaha, Sonia Tandon Wimalasena, et al.
Frontiers in Medicine|July 21, 2025
Baseline predictors for 28-day COVID-19 severity and mortality among hospitalized patients: results from the IMPACC studyJintong Hou, Benjamin Haslund-Gourley, Joann Diray-Arce, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 2025
Evaluating COVID-19 severity prediction and immune dynamics with NULISAseq: Insights from the IMPACC studyKoji Abe, Tyson H Holmes, Tran T Nguyen, et al.
Ebiomedicine|August 11, 2022
Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC studyAl Ozonoff, Joanna Schaenman, Naresh Doni Jayavelu, et al.
Research Square|June 30, 2025
Empiric Azithromycin in COVID-19 Impacts the Respiratory Microbiome and Antimicrobial Resistome without Anti-inflammatory BenefitCharles Langelier, Abigail Glascock, Cole Maguire, et al.
The Journal of Allergy and Clinical Immunology. Global|July 25, 2025
Type 2 immune responses are associated with less severe COVID-19 in a hospitalized cohortNaresh Doni Jayavelu, Jingjing Qi, Carly E Milliren, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 4, 2015
Update on biomarkers in neuromyelitis opticaEsther Melamed, Michael Levy, Patrick J Waters, et al.
Medrxiv : the Preprint Server for Health Sciences|February 24, 2025
Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factorsNaresh Doni Jayavelu, Hady Samaha, Sonia Tandon Wimalasena, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2025
Identification of a multi-omics factor predictive of long COVID in the IMPACC studyGisela Gabernet, Jessica Maciuch, Jeremy P Gygi, et al.
JCI Insight|July 3, 2025
MICBG406A polymorphism reduces risk of mechanical ventilation and death during viral acute lung injuryHarry Pickering, Narges Alipanah-Lechner, Ernie Chen, et al.
Communications Medicine|January 3, 2026
Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factorsNaresh Doni Jayavelu, Hady Samaha, Sonia Tandon Wimalasena, et al.
Frontiers in Medicine|July 21, 2025
Baseline predictors for 28-day COVID-19 severity and mortality among hospitalized patients: results from the IMPACC studyJintong Hou, Benjamin Haslund-Gourley, Joann Diray-Arce, et al.
Pageof 6